bw 373u86 has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KJ; Childers, SR; Fleming, LM; McNutt, RW; Selley, DE | 1 |
| Han, JS; Wang, XM; Wang, Y | 1 |
2 other study(ies) available for bw 373u86 and Neuroblastoma
| Article | Year |
|---|---|
BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Topics: Adenylyl Cyclase Inhibitors; Amino Acid Sequence; Animals; Benzamides; Brain; Corpus Striatum; GTP Phosphohydrolases; GTP-Binding Proteins; Guanine Nucleotides; Hydrogen-Ion Concentration; Kinetics; Male; Membranes; Molecular Sequence Data; Neuroblastoma; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Second Messenger Systems; Sodium; Stimulation, Chemical; Tumor Cells, Cultured | 1993 |
[Inhibition of the expression of delta opioid receptor mRNA by long-term exposure of NG-108-15 cell line to delta opioid agonists].
Topics: Analgesics, Opioid; Animals; Benzamides; Enkephalin, D-Penicillamine (2,5)-; Gene Expression; Glioma; Hybrid Cells; Mice; Neuroblastoma; Piperazines; Rats; Receptors, Opioid, delta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1998 |